Literature DB >> 19633453

Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats.

Fedor Simko1, Olga Pechanova, Vaclav Pelouch, Kristina Krajcirovicova, Martina Mullerova, Kristina Bednarova, Michaela Adamcova, Ludovit Paulis.   

Abstract

OBJECTIVE: Melatonin was shown to reduce blood pressure, oxidative load and to increase nitric oxide bioavailability predisposing melatonin to have antiremodelling potential.
DESIGN: The aim of this study was to show whether melatonin can reverse left ventricular remodelling in spontaneously hypertensive rats (SHR) and to compare this potential protective effect with captopril, spironolactone, or simvastatin.
METHODS: Six groups of 3-month old rats (eight per group) were treated for 5 weeks: control untreated Wistar rats, control SHR, SHR plus melatonin (10 mg/kg per 24 h), SHR plus captopril (100 mg/kg per 24 h), SHR plus spironolactone (200 mg/kg per 24 h) and SHR plus simvastatin (10 mg/kg per 24 h). Their systolic blood pressure (SBP) was measured by the tail-cuff method. The relative weights of the left ventricle, nitric oxide synthase (NOS) activity, endothelial NOS and nuclear factor kappa B (NF-kappaB) protein expression, conjugated dienes concentration, level of collagenous proteins and hydroxyproline were measured.
RESULTS: SBP was reduced by all drugs investigated but most prominently by captopril in SHR. The activity of NOS and endothelial NOS expression increased in the left ventricles of SHR compared with controls. Melatonin and spironolactone further increased NOS expression. Left ventricular oxidative load, estimated by NF-kappaB expression and conjugated dienes concentration, increased in SHR. Only melatonin reduced NF-kappaB expression and decreased conjugated diens concentration. Only captopril reduced left ventricular hypertrophy in SHR, whereas melatonin reduced collagenous protein concentration and hydroxyproline content in the left ventricle.
CONCLUSION: It is concluded that although melatonin, in comparison with captopril, did not reverse left ventricle hypertrophy, it reversed left ventricular fibrosis. This protection by melatonin may be caused by its prominent antioxidative effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19633453     DOI: 10.1097/01.hjh.0000358830.95439.e8

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  21 in total

1.  Systemic antioxidant properties of L-carnitine in two different models of arterial hypertension.

Authors:  Alfonso Mate; José L Miguel-Carrasco; María T Monserrat; Carmen M Vázquez
Journal:  J Physiol Biochem       Date:  2010-05-27       Impact factor: 4.158

2.  The presence and localization of melatonin receptors in the rat aorta.

Authors:  Martin Schepelmann; Lubos Molcan; Hana Uhrova; Michal Zeman; Isabella Ellinger
Journal:  Cell Mol Neurobiol       Date:  2011-06-22       Impact factor: 5.046

3.  Melatonin reduces oxidative stress and cardiovascular changes induced by stanozolol in rats exposed to swimming exercise.

Authors:  Gustavo Barbosa Dos Santos; Marcelo José Machado Rodrigues; Estela Maria Gonçalves; Maria Cristina Cintra Gomes Marcondes; Miguel Arcanjo Areas
Journal:  Eurasian J Med       Date:  2013-10

4.  Captopril reduces cardiac inflammatory markers in spontaneously hypertensive rats by inactivation of NF-kB.

Authors:  José L Miguel-Carrasco; Sonia Zambrano; Antonio J Blanca; Alfonso Mate; Carmen M Vázquez
Journal:  J Inflamm (Lond)       Date:  2010-05-12       Impact factor: 4.981

Review 5.  The Impact of microRNAs in Renin-Angiotensin-System-Induced Cardiac Remodelling.

Authors:  Michaela Adamcova; Ippei Kawano; Fedor Simko
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

Review 6.  Knocking out angiotensin II in the heart.

Authors:  Daniela Zablocki; Junichi Sadoshima
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

7.  Hypertension and cardiovascular remodelling in rats exposed to continuous light: protection by ACE-inhibition and melatonin.

Authors:  Fedor Simko; Olga Pechanova; Kristina Repova Bednarova; Kristina Krajcirovicova; Peter Celec; Natalia Kamodyova; Stefan Zorad; Jarmila Kucharska; Anna Gvozdjakova; Michaela Adamcova; Ludovit Paulis
Journal:  Mediators Inflamm       Date:  2014-07-06       Impact factor: 4.711

Review 8.  Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.

Authors:  Moshe Laudon; Anat Frydman-Marom
Journal:  Int J Mol Sci       Date:  2014-09-09       Impact factor: 5.923

Review 9.  Peripheral and central effects of melatonin on blood pressure regulation.

Authors:  Olga Pechanova; Ludovit Paulis; Fedor Simko
Journal:  Int J Mol Sci       Date:  2014-10-08       Impact factor: 5.923

10.  The right choice of antihypertensives protects primary human hepatocytes from ethanol- and recombinant human TGF-β1-induced cellular damage.

Authors:  Sabrina Ehnert; Teresa Lukoschek; Anastasia Bachmann; Juan J Martínez Sánchez; Georg Damm; Natascha C Nussler; Stefan Pscherer; Ulrich Stöckle; Steven Dooley; Sebastian Mueller; Andreas K Nussler
Journal:  Hepat Med       Date:  2013-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.